Single-arm phase II trial reports strong response with junctional cancer combination
A single-arm phase II trial of 40 patients with locally advanced esophagogastric junction adenocarcinoma reported high pathological response rates, manageable ...
A single-arm phase II trial of 40 patients with locally advanced esophagogastric junction adenocarcinoma reported high pathological response rates, manageable ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine